193 related articles for article (PubMed ID: 33500867)
1. Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia.
Elhassan M; Saidahmed O; Adebayo A; Archibald N
Cureus; 2021 Jan; 13(1):e12794. PubMed ID: 33500867
[TBL] [Abstract][Full Text] [Related]
2. Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab.
Talluri K; Lall N; Moreno MA; Nichols L; Bande D
Cureus; 2021 Feb; 13(2):e13475. PubMed ID: 33777563
[TBL] [Abstract][Full Text] [Related]
3. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient.
Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M
J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053
[TBL] [Abstract][Full Text] [Related]
4. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19.
Ioan P; Ribigan AC; Rusu O; Bratu IF; Badea RS; Antochi F
Am J Emerg Med; 2022 Jun; 56():393.e5-393.e8. PubMed ID: 35346531
[TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome during convalescence from COVID-19.
Michel-Chávez A; García-Grimshaw M; Chávez-Martínez OA; Cantú-Brito C; Romero-Sánchez GT; Flores-Silva FD; Merayo-Chalico FJ; Martínez-Carrillo FM; Barrera-Vargas A; Valdés-Ferrer SI
Int J Neurosci; 2023 Jun; 133(6):672-675. PubMed ID: 34370958
[No Abstract] [Full Text] [Related]
6. Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report.
Shimamoto Y; Sasaki H; Kasuno K; Watanabe Y; Sakashita S; Nishikawa S; Nishimori K; Morita S; Nishikawa Y; Kobayashi M; Fukushima S; Enomoto S; Takahashi N; Hamano T; Sakamaki I; Iwasaki H; Iwano M
BMC Nephrol; 2023 Sep; 24(1):286. PubMed ID: 37773103
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review.
Wang L; Wang Z; Huang R; Li W; Zheng D
Medicine (Baltimore); 2024 Feb; 103(5):e37192. PubMed ID: 38306528
[TBL] [Abstract][Full Text] [Related]
8. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature.
Motolese F; Ferrante M; Rossi M; Magliozzi A; Sbarra M; Ursini F; Marano M; Capone F; Travaglino F; Antonelli Incalzi R; Di Lazzaro V; Pilato F
J Neurol; 2021 Dec; 268(12):4407-4414. PubMed ID: 34291313
[TBL] [Abstract][Full Text] [Related]
9. Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: Case series and literature review.
Hixon AM; Thaker AA; Pelak VS
Eur J Neurol; 2021 Oct; 28(10):3289-3302. PubMed ID: 34115917
[TBL] [Abstract][Full Text] [Related]
10. Posterior reversible encephalopathy syndrome in patients with COVID-19.
Parauda SC; Gao V; Gewirtz AN; Parikh NS; Merkler AE; Lantos J; White H; Leifer D; Navi BB; Segal AZ
J Neurol Sci; 2020 Sep; 416():117019. PubMed ID: 32679347
[TBL] [Abstract][Full Text] [Related]
11. Posterior Reversible Encephalopathy Syndrome in Patients with Coronavirus Disease 2019: Two Cases and A Review of The Literature.
Anand P; Lau KHV; Chung DY; Virmani D; Cervantes-Arslanian AM; Mian AZ; Takahashi CE
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105212. PubMed ID: 33066908
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.
Kishfy L; Casasola M; Banankhah P; Parvez A; Jan YJ; Shenoy AM; Thomson C; AbdelRazek MA
J Neurol Sci; 2020 Jul; 414():116943. PubMed ID: 32474362
[TBL] [Abstract][Full Text] [Related]
13. Posterior Reversible Encephalopathy Syndrome Onset Within 24 Hours Following Moderna mRNA Booster COVID-19 Vaccination: Vaccine Adverse Event Vs. Hypertension?
McCullough J; Ahmad M; Tam I; Portnoy R; Ng J; Zachary K; Kaell A
Cureus; 2022 May; 14(5):e24919. PubMed ID: 35706738
[TBL] [Abstract][Full Text] [Related]
14. [Posterior reversible encephalopathy syndrome].
Petrović B; Kostić V; Sternić N; Kolar J; Tasić N
Srp Arh Celok Lek; 2003; 131(11-12):461-6. PubMed ID: 15114789
[TBL] [Abstract][Full Text] [Related]
15. Posterior Reversible Leukoencephalopathy Syndrome in a Patient after Acute COVID-19 Infection.
Kobaidze K; Shin YM; Japaridze M; Karakis I; Wu X
Case Rep Neurol Med; 2021; 2021():5564802. PubMed ID: 33996162
[TBL] [Abstract][Full Text] [Related]
16. Posterior Reversible Encephalopathy Syndrome in COVID-19 Disease: a Case-Report.
Llansó L; Urra X
SN Compr Clin Med; 2020; 2(10):1900-1902. PubMed ID: 32864576
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-related Posterior Reversible Encephalopathy Syndrome in an Adult ICU Patient in Ireland.
Lal S; Khan E; Diviney D; Thomas J; Hassan T; Counihan I
J Coll Physicians Surg Pak; 2021 Jan; 31(1):S87-S89. PubMed ID: 34530540
[TBL] [Abstract][Full Text] [Related]
18. Transient cortical blindness in posterior reversible encephalopathy syndrome after postpartum eclampsia.
Sesar A; Cavar I; Sesar AP; Sesar I
Taiwan J Ophthalmol; 2018; 8(2):111-114. PubMed ID: 30038892
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published Cases.
Wijeratne T; Wijeratne C; Karimi L; Sales C; Crewther SG
Front Neurol; 2020; 11():600544. PubMed ID: 33584499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
